Published: 1 July 2022
Author(s): Raúl Ramos, Pedro Moliner, Josep Comin-Colet
Issue: August 2022
Section: Commentary

Heart failure (HF) is an extremely relevant chronic disease impacting on quality of life and prognosis. Furthermore, the increasing prevalence of HF leads to a huge number of admissions and entails an important use of resources and healthcare costs [1]. For these reasons, the optimization of its management is crucial, including early diagnosis, pharmacological treatment, cardiac devices, HF community programmes, etc.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.